PULSE BIOSCIENCES, INC.
PULSE BIOSCIENCES, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash And Cash Equivalents At Carrying Value | 102 | 68 | 81 | 95 | 106 | 119 | 118 | 79 | 26 | 35 | 44 | 50 | |||||
Assets Current | |||||||||||||||||
Assets Current | 106 | 71 | 83 | 97 | 108 | 121 | 119 | 80 | 27 | 36 | 45 | 52 | |||||
Accounts Receivable Net Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 4 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | |||||
Finite Lived Intangible Assets Net | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | |||||
Goodwill | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Operating Lease Right Of Use Asset | 5 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | |||||
Other Assets Noncurrent | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | |||||
Assets | 116 | 82 | 95 | 109 | 120 | 133 | 132 | 93 | 40 | 49 | 59 | 66 | |||||
Accounts Payable Current | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | |||||
Accrued Liabilities Current | 6 | 5 | 4 | 5 | 5 | 4 | 7 | 4 | 3 | 2 | 4 | 3 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 11 | 10 | 8 | 10 | 9 | 8 | 10 | 7 | 6 | 5 | 7 | 5 | |||||
Operating Lease Liability Current | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Notes Payable Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Operating Lease Liability Noncurrent | 5 | 6 | 6 | 6 | 7 | 7 | 8 | 7 | 7 | 8 | 8 | 8 | |||||
Liabilities | 16 | 15 | 14 | 16 | 16 | 15 | 18 | 14 | 13 | 13 | 15 | 14 | |||||
Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | 100 | 66 | 81 | 93 | 104 | 118 | 115 | 79 | 27 | 36 | 44 | 52 | |||||
Additional Paid In Capital Common Stock | 606 | 548 | 544 | 538 | 531 | 526 | 505 | 450 | 385 | 383 | 381 | 377 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Retained Earnings Accumulated Deficit | -507 | -482 | -463 | -446 | -426 | -407 | -391 | -371 | -358 | -347 | -337 | -325 | |||||
Liabilities And Stockholders Equity | 116 | 82 | 95 | 109 | 120 | 133 | 132 | 93 | 40 | 49 | 59 | 66 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 71 | 68 | 68 | 68 | 67 | 67 | 66 | 62 | 55 | 55 | 55 | 55 | |||||
Shares Outstanding | 71 | 68 | 68 | 68 | 67 | 67 | 66 | 62 | 55 | 55 | 55 | 55 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.53% | 7.77% | 29.63% | - | - | - | - | - | - | - | - | - |
| 2025 | 2.70% | -10.50% | -11.39% | 0.07% | 27.75% | 12.12% | -15.86% | -11.49% | -7.25% | -14.00% | -25.56% | -23.92% |
| 2024 | 51.97% | 47.24% | 124.61% | -7.26% | -14.43% | -0.45% | -0.23% | 1.47% | -0.62% | 11.31% | 4.97% | -4.91% |
| 2023 | - | - | - | -31.87% | -41.08% | -39.04% | 75.23% | 66.91% | 68.76% | -17.45% | -10.33% | 38.12% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 9.63 | 7.26 | 10.53 | 10.02 | 12.05 | 15.58 | 11.88 | 11.93 | 4.57 | 7.06 | 6.76 | 9.50 | |||||
| Quick Ratio | 9.27 | 6.99 | 10.22 | 9.82 | 11.85 | 15.37 | 11.74 | 11.72 | 4.39 | 6.87 | 6.61 | 9.28 | |||||
| Working Capital | 94.72M | 61.33M | 75.50M | 87.46M | 99.18M | 113.15M | 109.39M | 73.67M | 21.28M | 30.77M | 38.62M | 46.19M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.16 | 0.23 | 0.17 | 0.17 | 0.15 | 0.13 | 0.15 | 0.18 | 0.50 | 0.35 | 0.33 | 0.26 | |||||
| Interest Coverage TTM | -27.51 | -22.00 | -18.28 | -18.45 | -16.98 | -18.37 | -20.91 | -20.25 | -21.89 | -21.44 | -23.66 | -23.49 | |||||
| Debt Ratio | 0.14 | 0.19 | 0.15 | 0.15 | 0.13 | 0.11 | 0.13 | 0.15 | 0.33 | 0.26 | 0.25 | 0.21 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | |||||
| Days Sales Outstanding TTM | 37.58 | 76.30 | 285.74 | 63.66 | - | - | - | - | - | - | - | - | |||||
| Receivables Turnover TTM | 9.71 | 4.78 | 1.28 | 5.73 | - | - | - | - | - | - | - | - | |||||
Per Share Metrics | |||||||||||||||||
| Free Cash Flow Per Share TTM | -0.89 | -0.82 | -0.81 | -0.72 | -0.66 | -0.60 | -0.62 | -0.56 | -0.62 | -0.64 | -0.67 | -0.60 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 0.25% | - | - | - | - | - | - | - | - | - | - | - | |||||
| Operating Profit Margin TTM | -7,007.76% | -10,392.14% | -21,982.57% | -91,798.84% | - | - | - | - | - | - | - | 442,066.67% | |||||
| Net Profit Margin TTM | -6,755.78% | -9,929.03% | -20,794.57% | -86,898.84% | - | - | - | - | - | - | - | 438,600.00% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | - | - | - | - | - | - | - | -100.00% | -100.00% | -100.00% | -100.00% | -100.58% | |||||
| Net Income Growth (1Y) | 17.68% | 23.78% | 35.82% | 61.99% | 54.54% | 41.59% | 26.95% | 16.87% | -6.24% | -16.63% | -27.85% | -39.01% | |||||
| EPS Growth (1Y) | 14.41% | 22.20% | 17.69% | 46.80% | 31.35% | 20.50% | 8.12% | 8.83% | -24.43% | -45.43% | -50.77% | -60.15% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -23.97 | -19.69 | -12.71 | -15.96 | -14.92 | -17.93 | -18.97 | -23.22 | -14.54 | -11.69 | -14.42 | -5.81 | |||||
| P/B TTM | 19.29 | 22.14 | 11.47 | 12.87 | 9.72 | 9.12 | 8.85 | 13.54 | 23.73 | 13.71 | 13.72 | 4.39 | |||||
| P/S TTM | 1,619.34 | 1,954.73 | 2,643.82 | 13,868.77 | - | - | - | - | - | - | - | -25,463.33 | |||||
| Market Cap | 1.92B | 1.47B | 925.34M | 1.19B | 1.02B | 1.08B | 1.02B | 1.07B | 639.84M | 497.55M | 608.78M | 229.17M | |||||
| Enterprise Value | 1.82B | 1.40B | 844.60M | 1.10B | 908.84M | 960.78M | 898.66M | 992.06M | 613.65M | 462.67M | 564.42M | 178.78M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -61.39M | -55.50M | -54.44M | -48.77M | -44.74M | -40.25M | -36.47M | -34.10M | -35.54M | -36.34M | -33.16M | -34.34M | |||||
| Net Debt | -101.62M | -68.32M | -80.74M | -95.21M | -106.35M | -119.28M | -118.04M | -79.03M | -26.20M | -34.89M | -44.37M | -50.39M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
PULSE BIOSCIENCES, INC. (PLSE) — SEC Financial Statements & Analysis
PULSE BIOSCIENCES, INC. (PLSE) is a surgical & medical instruments & apparatus company, incorporated in DE. PULSE BIOSCIENCES, INC. trades on Nasdaq as: PLSE. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), PULSE BIOSCIENCES, INC. reported a -100.00% year-over-year revenue growth, a Gross Profit Margin of 0.25% (TTM), a Debt-to-Equity ratio of 0.16x, a Price-to-Sales (P/S) ratio of 1619.34x (TTM), a Price-to-Book (P/B) ratio of 19.29x (TTM), at a market cap of $1.92B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -100.00%
- Gross Profit Margin TTM
- 0.25%
- Debt To Equity
- 0.16x
- P/S TTM
- 1619.34x
- P/B TTM
- 19.29x
- Market Cap
- $1.92B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PULSE BIOSCIENCES, INC. in?
PULSE BIOSCIENCES, INC. (PLSE) operates in the Surgical & Medical Instruments & Apparatus industry.
What is PLSE's market cap?
PULSE BIOSCIENCES, INC. (PLSE) has a market capitalization of $1.92B as of 2026-06-30.
What exchange does PLSE trade on?
PULSE BIOSCIENCES, INC. (PLSE) trades on the Nasdaq.
Where is PULSE BIOSCIENCES, INC. incorporated?
PULSE BIOSCIENCES, INC. is incorporated in DE.